These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9471386)

  • 1. [The clinico-immunological effects of immunotherapy in patients with acute pyelonephritis].
    Driianskaia VE
    Lik Sprava; 1997; (4):89-92. PubMed ID: 9471386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The clinico-immunological effects of T-activin in the combined treatment of patients with acute suppurative pyelonephritis].
    Vozianov AF; Drannik GN; Pasechnikov SP; Driianskaia VE; Petrovskaia IA; Kushko LIa; Ozvinchuk II; Potrebinskiĭ VM; Milinevskiĭ VA
    Lik Sprava; 1995; (9-12):81-3. PubMed ID: 8983802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The correction of immunodeficiency states in patients with acute suppurative pyelonephritis].
    Buglova SE; Plisan SO
    Urol Nefrol (Mosk); 1991; (2):17-21. PubMed ID: 2063497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of T-activin and irradiation with a helium-neon laser on the status of the interleukin-2-dependent component of the proliferative response of mononuclear cells in rheumatoid arthritis].
    Parnes EIa; Alikhanov BA; Tkomachev IuK; Muromtsev AV
    Fiziol Cheloveka; 1995; 21(4):143-9. PubMed ID: 7589960
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of endovascular helium-neon laser therapy on the immune status of patients with acute calculous pyelonephritis].
    Siniukhin VN; Ianenko EK; Safanov RM; Khamaganova EG; Borisik VI
    Urol Nefrol (Mosk); 1996; (6):9-11. PubMed ID: 9036617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunocorrective therapy of pyelonephritis in children].
    Kirillov VI; Zernov NG; Arion VIa; Tebloeva LT; Riabchikov OP
    Urol Nefrol (Mosk); 1989; (5):17-21. PubMed ID: 2595860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinico-immunological effects of leukinferon in the treatment of patients with acute suppurative pyelonephritis].
    Vozianov AF; Kuznetsov VP; Driianskaia VE; Pasechnikov SP; Ozvinchuk II; Fedoruk GV; Drannik GN
    Lik Sprava; 1997; (1):88-92. PubMed ID: 9221157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinico-immunological effects of leukinferon in the treatment of patients with acute suppurative pyelonephritis].
    Vozianov AS; Kuznetsova VP; Driianskaia VE; Pasechnikov SP; Ozvinchuk II; Musiĭ MIa; Fedorchuk GV; Beliaev DL; Dranik GN
    Urol Nefrol (Mosk); 1994; (3):8-11. PubMed ID: 8079417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Present-day concepts concerning immunoprophylaxis and immunotherapy of surgical infections].
    Pinegin BV; Andronova TM; Karsonova MI; Khaitov RM
    Anesteziol Reanimatol; 1999; (3):61-7. PubMed ID: 10458041
    [No Abstract]   [Full Text] [Related]  

  • 10. [From transplantation of the thymus to molecular reconstruction of the immune system].
    Arion VIa; Morozov IuI; Petrov RV; Lopukhin IuM
    Vestn Ross Akad Med Nauk; 1999; (5):15-9. PubMed ID: 10394294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of T-activin in the intensive therapy of the postoperative period in gestosis patients].
    Ianiushina VV
    Anesteziol Reanimatol; 1992; (4):42-5. PubMed ID: 1485674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and immunological studies in borderline mental disorders: problems and solutions].
    Aleksandrovskiĭ IuA; Chekhonin VP
    Vestn Ross Akad Med Nauk; 1999; (7):12-5. PubMed ID: 10467878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the effectiveness of immunomodulators in the treatment of patients with postoperative suppurative-septic complications].
    Bulava GV; Nikulina VP
    Khirurgiia (Mosk); 1996; (2):104-7. PubMed ID: 8754918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of immunological indices for assessing the severity of the course of periodontitis and treatment efficacy].
    Bazhanov NN; Ter-Asaturov GP; Kassin VIu; Ivaniushko TP; Arion VIa; Simonova AV
    Stomatologiia (Mosk); 1996; 75(1):15-8. PubMed ID: 8658566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and immunologic effects of T-activin therapy in early stage melanoma patients.
    Stanojević-Bakić N; Milosević D; Vucković-Dekić L; Sasić M; Marković L
    Neoplasma; 1996; 43(4):245-52. PubMed ID: 8931749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel immunotherapeutic strategies for pyelonephritis.
    Tsaganos T; Giamarellos-Bourboulis EJ
    Immunotherapy; 2016; 8(1):89-96. PubMed ID: 26641200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynamics of the immune status of patients with mycosis of the feet and concomitant eczema during T-activin therapy].
    Iutskovskiĭ AD; Fedotov VP; Leshchenko GM
    Vestn Dermatol Venerol; 1986; (7):17-21. PubMed ID: 3765804
    [No Abstract]   [Full Text] [Related]  

  • 18. [The potentials of local and intravascular laser irradiation for eliminating the immunological disorders in patients with chronic pyelonephritis].
    Neĭmark AI; Malazoniia ZT; Karabasova EB
    Urol Nefrol (Mosk); 1995; (2):27-9. PubMed ID: 7540338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunotherapy for the treatment of acute appendicitis in children].
    Bulanova AA; Akhanzaripov ZA
    Khirurgiia (Mosk); 1994 Aug; (8):34-6. PubMed ID: 7990319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunity and the possibilities for immunomodulation in acute pyelonephritis].
    Vozianov AF; Drannik GN; Petrovskaia IA; Kushko LIa; Pasechnikov SP; Pshegornitskiĭ IV; Ozvinchuk II; Musiĭ MIa; Listopad NK; Pogrebinskiĭ VM
    Urol Nefrol (Mosk); 1991; (5):30-4. PubMed ID: 1755120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.